mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0005 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.001 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |